These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2037702)

  • 21. Guanabenz for adolescent hypertension.
    Walson PD; Rath A; Kilbourne K; Deitch MW
    Pediatr Pharmacol (New York); 1984; 4(1):1-6. PubMed ID: 6739181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertension in patients with diabetes mellitus: treatment with a centrally acting agent.
    Weber MA; Drayer JI; Deitch MW
    J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S823-9. PubMed ID: 6084133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effects of captopril and atenolol in essential hypertension.
    Andrén L; Karlberg BE; Svensson A; Ohman P; Nilsson OR; Hansson L
    Acta Med Scand; 1985; 217(2):155-60. PubMed ID: 3887847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guanabenz versus methyldopa in the therapy of mild-to-moderate hypertension.
    Rosendorff C
    S Afr Med J; 1982 Sep; 62(13):435-7. PubMed ID: 7051365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Captopril in mild and moderate arterial hypertension resistant to diuretic therapy. A multicenter study].
    Franco RJ; Curi PR; Kohlmann Júnior O; Leite JB; Spritzer N; Lorga AM; Salomão Filho A; Ferreira Filho SR; Chuster M; Mion Júnior DM
    Arq Bras Cardiol; 1992 Mar; 58(3):237-42. PubMed ID: 1340205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of hypertensive crisis with captopril].
    Biollaz J; Waeber B; Turini GA; Schaller MD; Brunner HR
    Schweiz Med Wochenschr; 1983 Dec; 113(52):2006-7. PubMed ID: 6364338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential of garlic and its active constituent, S-allyl cysteine, as antihypertensive and cardioprotective in presence of captopril.
    Asdaq SM; Inamdar MN
    Phytomedicine; 2010 Nov; 17(13):1016-26. PubMed ID: 20739164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of guanabenz in adolescent hypertension.
    Walson PD; Graves P; Rath A; Kilbourne K; Deitch MW
    J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S814-7. PubMed ID: 6084131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-response effect of sublingual captopril in hypertensive crises.
    Castro del Castillo A; Rodriguez M; Gonzalez E; Rodriguez F; Estruch J
    J Clin Pharmacol; 1988 Jul; 28(7):667-70. PubMed ID: 3063729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of captopril injection in patients with moderate to severe hypertension.
    Lacourcière Y; Lebel M; Graney WF; Forchette CA; Block AJ
    Am J Hypertens; 1990 Oct; 3(10):769-74. PubMed ID: 2222943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ketanserin and captopril interaction in the treatment of essential hypertensives.
    Lavezzaro G; Ladetto PE; Valente M; Stramignoni D; Zanna C; Assogna G; Salvetti A
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():119-22. PubMed ID: 2285641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of guanabenz on blood pressure responses to posture and exercise.
    Dziedzic SW; Elijovich F; Felton K; Yeager K; Krakoff LR
    Clin Pharmacol Ther; 1983 Feb; 33(2):151-5. PubMed ID: 6337003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of a centrally acting antihypertensive agent and beta-adrenergic blocking agents for the treatment of hypertension.
    Morgan TO
    J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S808-13. PubMed ID: 6084130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of guanabenz in hypertensive patients with moderate renal insufficiency.
    Dubrow A; Mittman N; DeCola P; Westerman M; Flamenbaum W
    J Clin Hypertens; 1985 Dec; 1(4):322-5. PubMed ID: 3836301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Captopril and nifedipine in combination for moderate to severe essential hypertension.
    Singer DR; Markandu ND; Shore AC; MacGregor GA
    Hypertension; 1987 Jun; 9(6):629-33. PubMed ID: 3294594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of guanabenz on sodium and water homeostasis.
    Braden G; Alvis R; Walker BR; Cox M
    J Clin Hypertens; 1987 Dec; 3(4):397-404. PubMed ID: 3453382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low doses of angiotensin converting enzyme inhibitors and angiotensin type 1 blockers have a synergistic effect but high doses are less than additive.
    Morgan T; Griffiths C; Delbridge L
    Am J Hypertens; 2002 Nov; 15(11):1003-5. PubMed ID: 12441223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive efficacy and safe use of once-daily sustained-release diltiazem in the elderly: a comparison with captopril. The Dilcacomp Study Group.
    Nicaise J; Neveux E; Blondin P
    J Int Med Res; 1995; 23(4):244-53. PubMed ID: 7589767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of captopril as single therapy in hypertension and angina pectoris.
    Akhras F; Jackson G
    Int J Cardiol; 1991 Nov; 33(2):259-66. PubMed ID: 1743787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Guanabenz in primary hypertension].
    Román O; Sudy E; Gac JC; Baso B; Valenzuela MA
    Rev Med Chil; 1988 Mar; 116(3):247-53. PubMed ID: 3072635
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.